Gilles Guillon

6.8k total citations
166 papers, 5.7k citations indexed

About

Gilles Guillon is a scholar working on Social Psychology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Gilles Guillon has authored 166 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Social Psychology, 71 papers in Molecular Biology and 41 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Gilles Guillon's work include Neuroendocrine regulation and behavior (86 papers), Electrolyte and hormonal disorders (37 papers) and Receptor Mechanisms and Signaling (33 papers). Gilles Guillon is often cited by papers focused on Neuroendocrine regulation and behavior (86 papers), Electrolyte and hormonal disorders (37 papers) and Receptor Mechanisms and Signaling (33 papers). Gilles Guillon collaborates with scholars based in France, Canada and United States. Gilles Guillon's co-authors include Bernard Mouillac, Serge Jard, Nicole Gallo‐Payet, Eric Grazzini, M. Manning, Hans H. Zingg, Thierry Durroux, Bice Chini, M N Balestre and S. Stoev and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Gilles Guillon

165 papers receiving 5.4k citations

Peers

Gilles Guillon
Serge Jard France
F. Antoni Hungary
A. Negro‐Vilar United States
Philip J. Lowry United Kingdom
M J Brownstein United States
John C. Porter United States
Gilles Guillon
Citations per year, relative to Gilles Guillon Gilles Guillon (= 1×) peers Akito Tanoue

Countries citing papers authored by Gilles Guillon

Since Specialization
Citations

This map shows the geographic impact of Gilles Guillon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gilles Guillon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gilles Guillon more than expected).

Fields of papers citing papers by Gilles Guillon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gilles Guillon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gilles Guillon. The network helps show where Gilles Guillon may publish in the future.

Co-authorship network of co-authors of Gilles Guillon

This figure shows the co-authorship network connecting the top 25 collaborators of Gilles Guillon. A scholar is included among the top collaborators of Gilles Guillon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gilles Guillon. Gilles Guillon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alacreu‐Crespo, Adrián, Émilie Olié, Jérémy Deverdun, et al.. (2025). A pharmacological and brain imaging study of human vasopressin AVP1BR receptor functional polymorphisms. BMC Neuroscience. 26(1). 42–42.
2.
Fontanaud, Pierre, Amaury François, Philippe Colson, et al.. (2024). Neuropeptide therapeutics to repress lateral septum neurons that disable sociability in an autism mouse model. Cell Reports Medicine. 5(11). 101781–101781. 2 indexed citations
3.
Gaudard, Philippe, Hélène David, Patrice Bideaux, et al.. (2023). Involvement of Vasopressin in Tissue Hypoperfusion during Cardiogenic Shock Complicating Acute Myocardial Infarction in Rats. International Journal of Molecular Sciences. 24(2). 1325–1325. 1 indexed citations
4.
Guillon, Gilles, Aleksandra Olma, Maurice Manning, et al.. (2020). Correction of vasopressin deficit in the lateral septum ameliorates social deficits of mouse autism model. Journal of Clinical Investigation. 131(2). 32 indexed citations
5.
Corbani, Maïthé, Miguel Trueba, Magda Chafaï, et al.. (2017). Neuroanatomical distribution and function of the vasopressin V1B receptor in the rat brain deciphered using specific fluorescent ligands. General and Comparative Endocrinology. 258. 15–32. 25 indexed citations
6.
Murat, Brigitte, Dominic Devost, Véra Boulay, et al.. (2012). V1b and CRHR1 Receptor Heterodimerization Mediates Synergistic Biological Actions of Vasopressin and CRH. Molecular Endocrinology. 26(3). 502–520. 44 indexed citations
7.
Manning, M., Aleksandra Misicka, Aleksandra Olma, et al.. (2012). Oxytocin and Vasopressin Agonists and Antagonists as Research Tools and Potential Therapeutics. Journal of Neuroendocrinology. 24(4). 609–628. 330 indexed citations
8.
Manning, M., S. Stoev, Bice Chini, et al.. (2008). Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents☆. Progress in brain research. 170. 473–512. 230 indexed citations
9.
Tran, Dien, Nicole Stelly, M Claret, et al.. (2007). Vasopressin-induced morphological changes in polarized rat hepatocyte multiplets: Dual calcium-dependent effects. Cell Calcium. 43(1). 95–104. 6 indexed citations
10.
Guillon, Gilles, Ana Peña, Brigitte Murat, et al.. (2005). Position 4 analogues of [deamino-Cys1] arginine vasopressin exhibit striking species differences for human and rat V2/V1b receptor selectivity. Journal of Peptide Science. 12(3). 190–198. 10 indexed citations
11.
Granier, Sébastien, Sonia Terrillon, Robert Pascal, et al.. (2004). A Cyclic Peptide Mimicking the Third Intracellular Loop of the V2 Vasopressin Receptor Inhibits Signaling through Its Interaction with Receptor Dimer and G Protein. Journal of Biological Chemistry. 279(49). 50904–50914. 26 indexed citations
12.
Patel, Sandip, et al.. (2002). Inducible Nitric-oxide Synthase Attenuates Vasopressin-dependent Ca2+ Signaling in Rat Hepatocytes. Journal of Biological Chemistry. 277(37). 33776–33782. 9 indexed citations
13.
Colson, P, et al.. (2002). Haemodynamic effects of an angiotensin-converting enzyme inhibitor and angiotensin receptor antagonist during hypovolaemia in the anaesthetized pig. British Journal of Anaesthesia. 89(4). 599–604. 7 indexed citations
14.
Gal, Claudine Serradeil‐Le, Jean Wagnon, Jacques Simiand, et al.. (2002). Characterization of (2 S,4 R)-1-[5-Chloro-1-[(2,4-dimethoxyphenyl)sulfonyl]-3-(2-methoxy-phenyl)-2-oxo-2,3-dihydro-1 H-indol-3-yl]-4-hydroxy-N,N-dimethyl-2-pyrrolidine carboxamide (SSR149415), a Selective and Orally Active Vasopressin V1b Receptor Antagonist. Journal of Pharmacology and Experimental Therapeutics. 300(3). 1122–1130. 180 indexed citations
15.
Guillon, Gilles, Eric Grazzini, Christophe Breton, et al.. (1998). Vasopressin: A potent autocrine/paracrine regulator of mammal adrenal functions.. Endocrine Research. 24(3-4). 703–710. 37 indexed citations
16.
Aumelas, André, et al.. (1994). A New Series of Photoactivatable and Iodinatable Linear Vasopressin Antagonists. Journal of Medicinal Chemistry. 37(12). 1841–1849. 21 indexed citations
17.
Ibarrondo, Javier, et al.. (1991). Dual effects of ATP on phosphatidylinositol breakdown in rat hepatocyte membranes. Cellular Signalling. 3(6). 577–585. 4 indexed citations
18.
Gallo‐Payet, Nicole, L. A. Chouinard, Marie‐Noëlle Balestre, & Gilles Guillon. (1991). Mechanisms involved in the interaction of dopamine with angiotensin II on aldosterone secretion in isolated and cultured rat adrenal glomerulosa cells. Molecular and Cellular Endocrinology. 81(1-3). 11–23. 18 indexed citations
19.
Gallo‐Payet, Nicole, L. A. Chouinard, Marie‐Noëlle Balestre, & Gilles Guillon. (1990). Dual effects of dopamine in rat adrenal glomerulosa cells. Biochemical and Biophysical Research Communications. 172(3). 1100–1108. 13 indexed citations
20.
Guillon, Gilles, et al.. (1987). Mechanisms of phospholipase C activation: a comparison with the adenylate cyclase system. Biochimie. 69(4). 351–363. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026